Lv4
630 积分 2023-08-03 加入
[Consensus on clinical diagnosis and treatment of breast cancer with low expression of human epidermal growth factor receptor 2 (2022 edition)]
2天前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
2天前
已完结
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
27天前
已完结
[Expert consensus on clinical application of next-generation sequencing in advanced breast cancer (2024 edition)]
27天前
已完结
[Expert consensus on combined DNA and RNA next-generation sequencing of common driver genes in solid tumors (2025 version)]
1个月前
已完结
[PIK3CA gene mutations in Chinese women with HR+/HER2- breast cancer]
2个月前
已完结
乳腺癌PIK3CA突变的临床意义及其检测研究进
2个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
2个月前
已完结
[Chinese expert consensus on the diagnosis and treatment of advanced RET fusion-positive non-small cell lung cancer (2023 edition)]
2个月前
已完结
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
2个月前
已完结
皖公网安备34019202002308
